FDA NDC Directory · JSON-LD · Markdown
NDC 13668-720 · HUMAN PRESCRIPTION DRUG · TABLET
| Labeler / Manufacturer | TORRENT PHARMACEUTICALS LIMITED |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA207626 |
| Dosage form / route | TABLET · ORAL |
| Active ingredients | ROSUVASTATIN CALCIUM (5 mg/1) |
| Marketing started | 20230801 |
| Package count | 3 |
Source: openFDA. Public-domain (CC0).